Pages


Tuesday, October 05, 2021

Merck touts expensive new COVID drug while dismissing cheap ivermectin

The announcement Friday by Merck that it plans to apply for emergency approval of a new experimental oral antiviral treatment for COVID-19 is of particular interest to many physicians who have been hindered or completely blocked from treating their COVID patients off-label with an FDA-approved drug that already is produced by the pharmaceutical giant.
Posted by

7 comments:

  1. JamesOctober 5, 2021 at 12:35 PM

    Merck's pill is reported to have a high cancer risk.

    ReplyDelete
    Replies
    1. UnknownOctober 5, 2021 at 8:22 PM

      That's OK. Merk has drugs to fight cancer, too. /s

      Delete
  2. Henk VandenberghOctober 5, 2021 at 12:45 PM

    merckmectin, $500 per dose, one dose per month.

    ReplyDelete
  3. Marshall NOctober 5, 2021 at 12:55 PM

    Get some while you can. https://www.alldaychemist.com/ivermectin-12mg-austro.html

    ReplyDelete
  4. JmparretOctober 5, 2021 at 3:19 PM

    do not think this item is anything like ivermectin.
    Joe

    ReplyDelete
  5. Fa Cube ItchesOctober 5, 2021 at 10:55 PM

    We should start marketing a pill - 500mg of potassium cyanide. Guarantee that if you take one of our pills, you will never get COVID.

    Bet we'd make millions.

    ReplyDelete
  6. AnonymousOctober 5, 2021 at 11:17 PM

    There is a ton of data out there proving the efficacy of ivermectin is at least twice what they are claiming from an untested drug.

    There is no question Ivermectin works. Assertions to the contrary are bald faced lies.

    ReplyDelete

All comments are moderated due to spam, drunks and trolls.
Keep 'em civil, coherent, short, and on topic.

Subscribe to: Post Comments (Atom)